Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-09-18FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for amlodipine besylate (generic amlodipine) under an ANDA, allowing the update…
-
FDA approval · 2015-09-18FDA Approved: AMLODIPINE BESYLATE 2.5 MG — Supplemental Application (Oxford Pharmaceuticals, LLC)
FDA approved a supplemental application to add a 2.5 mg strength of amlodipine besylate for Oxford Pharmaceuticals’ generic product, expandi…
-
FDA approval · 2015-09-17FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approves a supplemental application for AMLODIPINE BESYLATE from Aurobindo Pharma Limited under an ANDA.
-
FDA approval · 2015-09-16FDA Approved: TRIBENZOR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Tribenzor (olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide) from Cosette Ph…
-
FDA approval · 2015-09-16FDA Approved: HYDROCHLOROTHIAZIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for HYDROCHLOROTHIAZIDE from Actavis Pharma, Inc., indicating an approved change to the product labe…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-09-16FDA Approved: NADOLOL — Original Application (Aurobindo Pharma Limited)
FDA approved Nadolol tablets as a generic drug under an Original Application (ANDA 201893) from Aurobindo Pharma Limited. This approval make…
-
FDA approval · 2015-09-14FDA Approved: FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (CIPLA USA INC.)
FDA approved a supplemental application for the generic combination drug fosinopril sodium and hydrochlorothiazide (CIPLA USA INC.), expandi…
-
FDA approval · 2015-09-10FDA Approved: TENORMIN — Supplemental Application (Almatica Pharma LLC)
The FDA approved a supplemental application for TENORMIN (atenolol) submitted by Almatica Pharma LLC.
-
FDA approval · 2015-09-08FDA Approved: NIFEDIPINE — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved Oceanside Pharmaceuticals' supplemental application for nifedipine (ANDA075289), authorizing a modification to the approved gen…
-
FDA approval · 2015-09-08FDA Approved: METOPROLOL TARTRATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Metoprolol Tartrate from Aurobindo Pharma Limited, a generic beta-blocker used in cardiovascular…
-
FDA approval · 2015-09-08FDA Approved: TELMISARTAN — Original Application (Amneal Pharmaceuticals of New York LLC)
FDA approves the original application for telmisartan (generic) from Amneal Pharmaceuticals of New York LLC. Telmisartan is used to treat hy…
-
FDA approval · 2015-09-03FDA Approved: TELMISARTAN — Original Application (Aurobindo Pharma Limited)
FDA approves the original application for telmisartan from Aurobindo Pharma Limited, a generic ARB for hypertension. The approval permits ma…
-
FDA approval · 2015-09-01FDA Approved: ENALAPRIL MALEATE — Supplemental Application (Amici Pharma, Inc)
FDA approved a supplemental application for enalapril maleate from Amici Pharma, Inc.
-
FDA approval · 2015-08-31FDA Approved: RAMIPRIL — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for ramipril (generic ACE inhibitor) under the ANDA, enabling a revised/exp…
-
FDA approval · 2015-08-25FDA Approved: ZESTRIL — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved Upsher-Smith Laboratories' supplemental application for ZESTRIL (lisinopril), resulting in approved labeling changes. Lisin…
-
FDA approval · 2015-08-25FDA Approved: ZESTORETIC — Supplemental Application (Almatica Pharma Inc.)
The FDA approved a supplemental application for ZESTORETIC (lisinopril and hydrochlorothiazide) from Almatica Pharma Inc.
-
FDA approval · 2015-08-25FDA Approved: BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Padagis US LLC)
The FDA approved a supplemental application for the fixed-dose combination benazepril hydrochloride and hydrochlorothiazide (Padagis US LLC)…
-
FDA approval · 2015-08-25FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Apotex Corp.)
FDA approves Apotex Corp.'s supplemental application for diltiazem hydrochloride (generic) under an abbreviated new drug application (ANDA).
-
FDA approval · 2015-08-25FDA Approved: ENALAPRIL MALEATE — Supplemental Application (OCEANSIDE PHARMACEUTICALS)
The FDA approved a supplemental application for enalapril maleate submitted by Oceanside Pharmaceuticals, marking an approved labeling actio…
-
FDA approval · 2015-08-25FDA Approved: VASERETIC — Supplemental Application (Bausch Health US, LLC)
The FDA approved a supplemental application for VASERETIC (enalapril maleate and hydrochlorothiazide) filed by Bausch Health US, LLC.
-
FDA approval · 2015-08-25FDA Approved: LISINOPRIL — Supplemental Application (Aurobindo Pharma Limited)
FDA granted supplemental approval for lisinopril from Aurobindo Pharma Limited under the ANDA program.
-
FDA approval · 2015-08-19FDA Approved: CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approves a supplemental application for candesartan cilexetil and hydrochlorothiazide filed by Mylan Pharmaceuticals Inc., approving a g…
-
FDA approval · 2015-08-17FDA Approved: ENALAPRIL MALEATE — Supplemental Application (Northstar RxLLC)
FDA approves Northstar RxLLC's supplemental application for enalapril maleate, confirming the approval of this generic ACE inhibitor.
-
FDA approval · 2015-08-17FDA Approved: ENALAPRIL MALEATE — Supplemental Application (Northstar RxLLC)
FDA approved a supplemental application for enalapril maleate filed by Northstar RxLLC.
-
FDA approval · 2015-08-13FDA Approved: METOPROLOL — Supplemental Application (Fresenius Kabi USA, LLC)
The FDA approved a supplemental application for metoprolol tartrate from Fresenius Kabi USA, LLC.